CoChat

Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction

Malmberg, K., Ryden, L., Hamstent, A., Herlitz, J., Waldenstrom, A., Wedel, H., on behalf of the DIGAMI study group · 1996 · European Heart Journal

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

Diabetic patients with acute myocardial infarction have a poor prognosis, which has been attributed to a higher incidence of congestive heart failure and fatal reinfarction. This study reports on the one-year morbidity and mortality in a randomized study with the aim of testing whether insulin-glucose infusion initiated as soon as possible after onset of myocardial infarction and followed by long-term subcutaneous insulin treatment may have a beneficial effect on outcome in diabetic patients. In all, 306 patients were recruited to the insulin-treated group, while 314 patients served as controls. The overall mortality after one year was 19% in the insulin group compared to 26% among controls (P < 0.05). The treatment effect was most pronounced in patients without prior insulin medication and at low cardiovascular risk. In this stratum the in-hospital mortality was reduced by 58% (P < 0.05) and the one-year mortality by 52% (P < 0.02). The most frequent cause of death in all patients was congestive heart failure (66%), but cardiovascular mortality (congestive heart failure, fatal reinfarction, sudden death and stroke) tended to be decreased in insulin-treated patients. However, this difference did not reach the level of statistical significance. The number of reinfarctions was 53 (28% fatal) in the insulin group compared to 55 (45% fatal) in the control group. The two groups did not differ as regards need for hospital care or coronary revascularization during the year of follow-up. In summary, left ventricular failure and fatal reinfarctions contribute to increased mortality in diabetic patients following acute myocardial infarction. Intensive insulin treatment lowered this mortality during one year of follow-up.

Overview

Integrity signals

Registry

Crossref · 10.1093/oxfordjournals.eurheartj.a015067

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 33 references

Cited by

See all 281

Metadata

Authors
Malmberg, K., Ryden, L., Hamstent, A., Herlitz, J., Waldenstrom, A., Wedel, H., & on behalf of the DIGAMI study group
Affiliations
  • Karolinska University Hospital (SE)
  • Sahlgrenska University Hospital (SE)
  • Nordic School of Public Health (SE)
Corresponding author
Malmberg, K.
Venue
European Heart Journal
Published
1996-09-01
Volume
17
Issue
9
Pages
1337-1344
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2109058702
Cited by
281
References
33
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 3 · 2021: 4 · 2020: 2 · 2019: 5 · 2018: 5 · 2017: 2 · 2016: 7 · 2015: 7 · 2014: 6 · 2013: 13 · 2012: 6
FWCI
8.97
Type
journal article
Language
en
Open access
closed
Locations
  • European Heart Journal (publishedVersion)
  • PubMed (publishedVersion)
  • Borås Academic Digital Archive (University of Borås) (submittedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
insulin therapy, acute myocardial infarction, diabetes mellitus, one-year mortality, congestive heart failure, subcutaneous insulin, in-hospital mortality, cardiovascular risk, coronary revascularization, stroke, sudden death
MeSH terms
Adult, Aged, Diabetes Mellitus, Type 1, Female, Humans, Infusions, Intravenous, Insulin, Male, Middle Aged, Morbidity, Myocardial Infarction, Prognosis, Prospective Studies, Sweden, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. https://app.cochat.ai/papers/10.1093/oxfordjournals.eurheartj.a015067
The paper
Malmberg, K., Ryden, L., Hamstent, A., Herlitz, J., Waldenstrom, A., Wedel, H., & on behalf of the DIGAMI study group. (1996). Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. European Heart Journal. https://doi.org/10.1093/oxfordjournals.eurheartj.a015067

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.